Rescuing the last-line therapy colistin against Gram-negative 'superbugs': increasing the therapeutic index by attenuation of nephrotoxicity

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1231/12/14

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$481,300.00